london euretina

This meeting has been awarded 20 CME credits

Security Notice

Please note that Kuoni are our only destination management company. Other venders indicating that are operating for the society should be ignored. We never use western union as a payment portal

Posters

Intravitreal ranibizumab for the treatment of choroidal neovascularization in multifocal choroiditis

Poster Details

First Author: O.Ruiz-Moreno SPAIN

Co Author(s):    P. Calvo   B. Abadia   J. Leciñena   C. Torrón         0   0 0   0 0   0 0   0 0

Abstract Details



Purpose:

To describe a case of a patient who developed multifocal choroiditis (MC) complicated with a choroidal neovascular (CNV) membrane treated with intravitreal ranibizumab.

Setting:

Case report at Miguel Servet University Hospital, Zaragoza (Spain)

Methods:

We present a case of a 62-year-old man, previously diagnosed with MC and sudden vision loss in the left eye (OS). A full ophthalmological examination was performed including biomicroscopy, fluorescein angiography (FA) and spectral domain (SD) Cirrus optical coherence tomography (OCT).

Results:

Best-corrected visual acuity (BCVA) was 20/200 in the right eye (OD) and 20/60 in the OS. The anterior segment was quiet in both eyes (OU). Intraocular pressure was 18mm Hg OU. Fundoscopy of the OS revealed a subretinal haemorrhage and some yellowish-gray lesions in the macular area. FA showed early hypofluorescence and late hyperfluorescence due to active leakage at the level of the haemorrhage, revealing a CNV membrane due to MC in the OS. SD Cirrus OCT revealed a neurosensory retinal detachment in the OS. Intravitreal injection of ranibizumab was performed in the OS with good response. BCVA improved to 20/20 but 2 months later it recurred. Three additional ranibizumab injections were administered whereby vision stabilized at 20/25. No leakage was observed in FA. The vision remained stable with no flare up for over 12 months

Conclusions:

Intravitreal ranibizumab therapy could be a good option for the treatment of CNV in MC that can improve vision and eliminate all inflammatory signs.

Back to previous
EURETINA, Temple House, Temple Road, Blackrock, Co Dublin. | Phone: 00353 1 2100092 | Fax: 00353 1 2091112 | Email: euretina@euretina.org

Privacy policyHotel Terms and Conditions Cancellation policy